原发性肝癌经肝动脉栓塞化疗术后再行肝切除的临床观察

A clinical study on hepatectomy following hepaticartery chemoembolization for primary hepatic carcinoma

１９８７年１月至１９９２年１２月，作者共为４８例经肝动脉栓塞化疗（ＨＡＣＥ）后肿瘤缩小的肝癌患者施行了肝切除术。全组无手术死亡。术后１、２、３年生存率分别为８４．６％、５７．２％和４４．９％。已有２例生存时间超过５年。本文对原发性肝癌（ＰＨＣ）经ＨＡＣＥ后再行切除的临床意义以及ＨＡＣＥ后再作肝切除的手术时机问题进行了讨论。

rom January 1987 to December 1992, 48 patientswith primary hepatic carinoma underwent hepatectomyafter tumor size reduction following hepatic arterychemoembolization (HACE). There were no operativedeaths. The postoperative 1, 2, 3 years survival rateswere 84. 6%, 57. 2% and 44. 9%, respectively. 2 casesof them have survived more than 5 years after operation. The clinical significance of hepatectomy followingHACE for primary hepatic carcinoma and surgical opportunity is discussed.